Market Cap 73.00M
Revenue (ttm) 0.00
Net Income (ttm) -22.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 99,500
Avg Vol 181,928
Day's Range N/A - N/A
Shares Out 14.54M
Stochastic %K 0%
Beta -0.88
Analysts Strong Sell
Price Target $21.20

Company Profile

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In...

Industry: Biotechnology
Sector: Healthcare
Phone: 913 942 2300
Address:
1901 West 47th Place, Kansas City, United States
RemitTekram
RemitTekram Sep. 13 at 5:48 PM
$CING I’ve seen more than one company sky rocket after spending years in a narrow channel at $5. Might start this one again.
0 · Reply
BigD12plus
BigD12plus Sep. 11 at 7:07 PM
$CING I might just buy back in at this level 🤔
0 · Reply
Spicy_Weeklies
Spicy_Weeklies Sep. 9 at 7:36 PM
$CING Bets on the next meaningful PR? Type A Meeting Date? Results? Resubmission?
1 · Reply
hossam94
hossam94 Sep. 9 at 2:38 PM
$CING I'm here with big position near to 36k shares ,didn't sell one share even it reach 11.89 from a while, not sell one share less than 25$
1 · Reply
hossam94
hossam94 Sep. 8 at 7:01 PM
$CING comeback to cing , I don't sell my position, I added today 940 shares ,big news coming soon and good squeeze to 12$ and more💪
0 · Reply
Merlintrader
Merlintrader Sep. 6 at 7:54 PM
Cingulate ($CING) Stock Hub: Three Months After the CRL, No Resubmission Date, $28.4 Million of Cash and a Runway Stated Into Mid-2027 Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/cingulate-inc-stock-hub/
0 · Reply
stockchacing
stockchacing Sep. 4 at 7:11 AM
$CING looking at the full video of unboxing biotech I feel very bullish about the future of CING! Wouldn't be surprised if we see a huge gain of market share already in Q1/27. Only thing to wait for is now PR with new PDUFA date, acc to Shane this shouldn't take too long any more. Adding more, before the news hit and we see double digits (again).
0 · Reply
ZacksResearch
ZacksResearch Sep. 3 at 5:19 PM
$CING Gains 8.1% in Three Months 🚀 Will the momentum continue in September? See what Wall Street expects next 👉 https://www.zacks.com/stock/research/CING/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-39490&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_39490
0 · Reply
Jacob_Berkstein
Jacob_Berkstein Sep. 2 at 8:21 PM
$AVGO $HPE if u have made losses here pls invest in $CING PTR platform $32 analyst price target
0 · Reply
Daman_Runnon
Daman_Runnon Sep. 2 at 8:08 PM
$CING Checking back and patiently waiting....
0 · Reply
Latest News on CING
Cingulate price target lowered to $9 from $10 at Roth Capital

2026-08-23T22:10:12.000Z - 21 days ago

Cingulate price target lowered to $9 from $10 at Roth Capital


Cingulate Earnings release: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 4 weeks ago

Cingulate Earnings release: Q2 2026


Cingulate Quarterly report: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 4 weeks ago

Cingulate Quarterly report: Q2 2026


Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

Jul 2, 2026, 8:30 AM EDT - 2 months ago

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®


Cingulate issues patent by USPTO for CTx-1301

2026-06-16T12:17:17.000Z - 2 months ago

Cingulate issues patent by USPTO for CTx-1301


Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Jun 16, 2026, 8:00 AM EDT - 2 months ago

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301


Cingulate issued complete response letter for CTx-1301 from FDA

2026-06-02T13:17:58.000Z - 3 months ago

Cingulate issued complete response letter for CTx-1301 from FDA


US FDA declines to approve Cingulate's ADHD drug

Jun 2, 2026, 8:08 AM EDT - 3 months ago

US FDA declines to approve Cingulate's ADHD drug


Cingulate Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 3 months ago

Cingulate Proxy statement: Proxy filing


Cingulate Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 3 months ago

Cingulate Proxy statement: Proxy filing


Cingulate price target lowered to $10 from $14 at Roth Capital

2026-05-19T15:00:40.000Z - 3 months ago

Cingulate price target lowered to $10 from $14 at Roth Capital


Cingulate Proxy statement: Proxy filing

May 18, 2026, 8:00 AM EDT - 3 months ago

Cingulate Proxy statement: Proxy filing


Cingulate Earnings release: Q1 2026

May 14, 2026, 8:00 AM EDT - 4 months ago

Cingulate Earnings release: Q1 2026


Cingulate Quarterly report: Q1 2026

May 14, 2026, 8:00 AM EDT - 4 months ago

Cingulate Quarterly report: Q1 2026


Cingulate Registration statement: Registration filing

Apr 14, 2026, 8:00 AM EDT - 5 months ago

Cingulate Registration statement: Registration filing


Cingulate Slides: Corporate presentation

Apr 1, 2026, 7:00 AM EDT - 5 months ago

Cingulate Slides: Corporate presentation


Cingulate Registration statement: Registration filing

Mar 23, 2026, 8:00 AM EDT - 5 months ago

Cingulate Registration statement: Registration filing


Cingulate price target lowered to $14 from $16 at Roth Capital

2026-03-22T22:30:08.000Z - 5 months ago

Cingulate price target lowered to $14 from $16 at Roth Capital


Cingulate Registration statement: Registration filing

Mar 20, 2026, 8:00 AM EDT - 5 months ago

Cingulate Registration statement: Registration filing


Cingulate files to sell 3.5M shares of common stock for holders

2026-03-20T11:46:09.000Z - 5 months ago

Cingulate files to sell 3.5M shares of common stock for holders


Cingulate announces U.S. patent notice of allowance

2026-03-18T12:12:11.000Z - 5 months ago

Cingulate announces U.S. patent notice of allowance


Cingulate reports Q4 net loss $6.3M vs. $6.2M last year

2026-03-18T12:05:55.000Z - 5 months ago

Cingulate reports Q4 net loss $6.3M vs. $6.2M last year


Cingulate sees cash runway into late 4Q26

2026-03-18T12:05:40.000Z - 5 months ago

Cingulate sees cash runway into late 4Q26


Cingulate Proxy statement: Proxy Filing

Mar 18, 2026, 8:00 AM EDT - 5 months ago

Cingulate Proxy statement: Proxy Filing


Cingulate Earnings release: Q4 2025

Mar 18, 2026, 7:00 AM EDT - 5 months ago

Cingulate Earnings release: Q4 2025


Cingulate Annual report: Q4 2025

Mar 18, 2026, 7:00 AM EDT - 5 months ago

Cingulate Annual report: Q4 2025


Why did Cingulate stock skyrocket today?

Mar 16, 2026, 1:26 PM EDT - 6 months ago

Why did Cingulate stock skyrocket today?


Cingulate Proxy statement: Proxy Filing

Mar 2, 2026, 7:00 AM EST - 6 months ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Feb 18, 2026, 7:00 AM EST - 6 months ago

Cingulate Proxy statement: Proxy Filing


Cingulate files $200M mixed securities shelf

2026-01-12T22:15:20.000Z - 8 months ago

Cingulate files $200M mixed securities shelf


Cingulate Registration statement: Registration Filing

Jan 12, 2026, 7:00 AM EST - 8 months ago

Cingulate Registration statement: Registration Filing


Cingulate price target lowered to $16 from $17 at Roth Capital

2025-11-19T12:40:10.000Z - 9 months ago

Cingulate price target lowered to $16 from $17 at Roth Capital


Cingulate price target lowered to $16 from $17 at Roth Capital

2025-11-19T00:55:07.000Z - 9 months ago

Cingulate price target lowered to $16 from $17 at Roth Capital


Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year

2025-11-13T13:16:41.000Z - 10 months ago

Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year


Cingulate Quarterly report: Q3 2025

Nov 13, 2025, 8:00 AM EST - 10 months ago

Cingulate Quarterly report: Q3 2025


Cingulate Earnings release: Q3 2025

Nov 13, 2025, 8:00 AM EST - 10 months ago

Cingulate Earnings release: Q3 2025


Cingulate names Downey as CCO to lead launch prep for CTx-1301

2025-11-10T13:25:38.000Z - 10 months ago

Cingulate names Downey as CCO to lead launch prep for CTx-1301


Cingulate Quarterly report: Q2 2025

Aug 19, 2025, 7:00 AM EDT - 1 year ago

Cingulate Quarterly report: Q2 2025


Cingulate Earnings release: Q2 2025

Aug 19, 2025, 7:00 AM EDT - 1 year ago

Cingulate Earnings release: Q2 2025


Cingulate Provides Management Team Update

Aug 15, 2025, 9:00 AM EDT - 1 year ago

Cingulate Provides Management Team Update


Cingulate Proxy statement: Proxy Filing

Aug 15, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Registration statement: Registration Filing

Jul 25, 2025, 8:00 AM EDT - 1 year ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Cingulate Registration statement: Registration Filing


Cingulate Earnings release: Q1 2025

May 8, 2025, 12:00 AM EDT - 1 year ago

Cingulate Earnings release: Q1 2025


Cingulate Quarterly report: Q1 2025

May 8, 2025, 12:00 AM EDT - 1 year ago

Cingulate Quarterly report: Q1 2025


Cingulate Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Annual report: Q4 2024

Mar 26, 2025, 9:00 AM EDT - 1 year ago

Cingulate Annual report: Q4 2024


Cingulate Earnings release: Q4 2024

Mar 26, 2025, 9:00 AM EDT - 1 year ago

Cingulate Earnings release: Q4 2024


Cingulate Quarterly report: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Cingulate Quarterly report: Q3 2024


Cingulate Earnings release: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Cingulate Earnings release: Q3 2024


Cingulate Registration statement: Registration Filing

Oct 7, 2024, 8:00 AM EDT - 1 year ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Oct 3, 2024, 8:00 AM EDT - 1 year ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Sep 27, 2024, 8:00 AM EDT - 1 year ago

Cingulate Registration statement: Registration Filing


Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

Sep 12, 2024, 8:30 AM EDT - 2 years ago

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301


Cingulate to Participate in Benzinga All Live Access Event

Aug 27, 2024, 4:30 PM EDT - 2 years ago

Cingulate to Participate in Benzinga All Live Access Event


Cingulate Announces Adjournment of Special Meeting

Aug 23, 2024, 4:45 PM EDT - 2 years ago

Cingulate Announces Adjournment of Special Meeting


Cingulate Proxy statement: Proxy Filing

Aug 23, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Registration statement: Registration Filing

Aug 19, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Quarterly report: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

Cingulate Quarterly report: Q2 2024


Cingulate Earnings release: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

Cingulate Earnings release: Q2 2024


Cingulate Proxy statement: Proxy Filing

Jul 22, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Registration statement: Registration Filing

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Proxy statement: Proxy Filing

Jul 12, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Jul 12, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Jun 28, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Jun 18, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Registration statement: Registration Filing

May 17, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Quarterly report: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Cingulate Quarterly report: Q1 2024


Cingulate Earnings release: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Cingulate Earnings release: Q1 2024


Cingulate Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Annual report: Q4 2023

Apr 1, 2024, 7:00 AM EDT - 2 years ago

Cingulate Annual report: Q4 2023


Cingulate Earnings release: Q4 2023

Apr 1, 2024, 7:00 AM EDT - 2 years ago

Cingulate Earnings release: Q4 2023


Cingulate to Attend DCAT Week 2024 in New York City

Mar 6, 2024, 6:45 AM EST - 2 years ago

Cingulate to Attend DCAT Week 2024 in New York City


Cingulate Announces Closing of $7.5 Million Public Offering

Feb 6, 2024, 4:15 PM EST - 2 years ago

Cingulate Announces Closing of $7.5 Million Public Offering


Cingulate Announces Pricing of $7.5 Million Public Offering

Feb 2, 2024, 9:15 AM EST - 2 years ago

Cingulate Announces Pricing of $7.5 Million Public Offering


Longtime Cingulate Controller Jennifer Callahan Promoted to CFO

Jan 29, 2024, 8:00 AM EST - 2 years ago

Longtime Cingulate Controller Jennifer Callahan Promoted to CFO


Cingulate Registration statement: Registration Filing

Jan 29, 2024, 7:00 AM EST - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Jan 12, 2024, 7:00 AM EST - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Nov 15, 2023, 7:00 AM EST - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Quarterly report: Q3 2023

Nov 13, 2023, 7:00 AM EST - 2 years ago

Cingulate Quarterly report: Q3 2023


Cingulate Earnings release: Q3 2023

Nov 13, 2023, 7:00 AM EST - 2 years ago

Cingulate Earnings release: Q3 2023


Cingulate to Host CNS Key Opinion Leader Panel in New York City

Oct 17, 2023, 2:22 PM EDT - 2 years ago

Cingulate to Host CNS Key Opinion Leader Panel in New York City


Cingulate Proxy statement: Proxy Filing

Oct 2, 2023, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Sep 22, 2023, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Inc. to Present at the LD Micro Main Event XVI

Sep 21, 2023, 1:30 PM EDT - 2 years ago

Cingulate Inc. to Present at the LD Micro Main Event XVI


Cingulate Inc. To Present at the LD Micro Main Event XVI

Sep 21, 2023, 11:23 AM EDT - 2 years ago

Cingulate Inc. To Present at the LD Micro Main Event XVI


RemitTekram
RemitTekram Sep. 13 at 5:48 PM
$CING I’ve seen more than one company sky rocket after spending years in a narrow channel at $5. Might start this one again.
0 · Reply
BigD12plus
BigD12plus Sep. 11 at 7:07 PM
$CING I might just buy back in at this level 🤔
0 · Reply
Spicy_Weeklies
Spicy_Weeklies Sep. 9 at 7:36 PM
$CING Bets on the next meaningful PR? Type A Meeting Date? Results? Resubmission?
1 · Reply
hossam94
hossam94 Sep. 9 at 2:38 PM
$CING I'm here with big position near to 36k shares ,didn't sell one share even it reach 11.89 from a while, not sell one share less than 25$
1 · Reply
hossam94
hossam94 Sep. 8 at 7:01 PM
$CING comeback to cing , I don't sell my position, I added today 940 shares ,big news coming soon and good squeeze to 12$ and more💪
0 · Reply
Merlintrader
Merlintrader Sep. 6 at 7:54 PM
Cingulate ($CING) Stock Hub: Three Months After the CRL, No Resubmission Date, $28.4 Million of Cash and a Runway Stated Into Mid-2027 Free Biotech Catalyst Calendar on Merlintrader. https://www.merlintrader.com/cingulate-inc-stock-hub/
0 · Reply
stockchacing
stockchacing Sep. 4 at 7:11 AM
$CING looking at the full video of unboxing biotech I feel very bullish about the future of CING! Wouldn't be surprised if we see a huge gain of market share already in Q1/27. Only thing to wait for is now PR with new PDUFA date, acc to Shane this shouldn't take too long any more. Adding more, before the news hit and we see double digits (again).
0 · Reply
ZacksResearch
ZacksResearch Sep. 3 at 5:19 PM
$CING Gains 8.1% in Three Months 🚀 Will the momentum continue in September? See what Wall Street expects next 👉 https://www.zacks.com/stock/research/CING/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-39490&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_39490
0 · Reply
Jacob_Berkstein
Jacob_Berkstein Sep. 2 at 8:21 PM
$AVGO $HPE if u have made losses here pls invest in $CING PTR platform $32 analyst price target
0 · Reply
Daman_Runnon
Daman_Runnon Sep. 2 at 8:08 PM
$CING Checking back and patiently waiting....
0 · Reply
Spicy_Weeklies
Spicy_Weeklies Sep. 2 at 2:11 PM
$CING Give it a watch. Come back to me when you figure out what they’re gonna call CTx-1301 after FDA approval.
1 · Reply
YoBee
YoBee Sep. 2 at 10:11 AM
$CING Full video of the unboxing bio interview that was done about a month and a half ago. The company was slowly releasing segments during this time. Great updates and information on the post CRL progress. https://youtu.be/9i1Wd-xgYgA?is=nrDrhS4cDZq9GQE-
0 · Reply
ccledez
ccledez Sep. 1 at 4:08 PM
$CING $GRCE $UNCY I asked Gemini (my favorite) And chatgpt (stupid name) who will resubmit Gemini said cing, then uncy, then grace Chatgpt said grace, cing, then uncy 😂
1 · Reply
Mr_Anderson007
Mr_Anderson007 Sep. 1 at 3:52 PM
$SLS Hey captain, did you just come from seeing your bfb Frankie Gerola? Just so everybody knows the good "captain" came to us after $CING shareholders ripped him a new one there. Then he got a bee in his bonnet or something but there is overlap here with some SLS & CING longs. So then he comes here AT SUB $10 spouting off & "talking" a big game & how he's going to short yada yada yada. Only to have the stock hit new highs of course. Then what was it you said last "captain"...oh right, something to the gist of "pump this up to the moon pumpers so I can then short it, hit me with your best shot"...ha ha ha...isn't that right captain? So what's the deal "captain"...did you short, waiting to short...ha ha ha...how convenient. But we will take you up on the increasing the price part "captain"... b/c yes we are wholly undervalued for what we have going on by a landslide. Yeah so MINIMUM $33 per share BEFORE REGAL FINAL ANALYSIS is the number. "I can do this all day"..."captain"! Time is a-ticking!
1 · Reply
ricksfeed
ricksfeed Aug. 31 at 2:52 PM
0 · Reply
Jomppaaz
Jomppaaz Aug. 31 at 2:41 PM
$CING 🔥
0 · Reply
Spicy_Weeklies
Spicy_Weeklies Aug. 27 at 5:57 PM
$CING Looks like higher highs and higher lows. Possibly forming a cup and handle over the past 8-10 weeks. If confirmed, this could quietly drift to the $7-8 range on technicals alone. That’s when I want them to give a real update. $SLS $FCEL $SPCX
1 · Reply
Jomppaaz
Jomppaaz Aug. 27 at 5:57 PM
$CING Sentiment 89 EXTREMELY BULLISH 🔥🔥
0 · Reply
activehybrid
activehybrid Aug. 27 at 2:25 PM
$CING as cingulate released q2 2026 results recently , first sentence is not the fda roadmap and provide any specific details on cmc Instead , they highlighted to have enough cash Hence , cingulate got two price cuts in August At least my messages are supported by price cuts , otherwise they don’t decrease the target price right ? But what is your supporting thesis except calling me a clown :-)
3 · Reply
Spicy_Weeklies
Spicy_Weeklies Aug. 27 at 1:43 PM
$CING 💊
0 · Reply
Jomppaaz
Jomppaaz Aug. 27 at 1:07 PM
$CING 💎
0 · Reply
StockTaking
StockTaking Aug. 27 at 10:57 AM
0 · Reply